Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Risk factors and outcome of COVID-19 in patients with hematological malignancies.
Exp Hematol Oncol. 2020 Aug 25;9:21. doi: 10.1186/s40164-020-00177-z. eCollection 2020.
Exp Hematol Oncol. 2020.
PMID: 32864192
Free PMC article.
Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
Marín-Sánchez A, Martínez-Fernández G, Gómez-Catalán I, Montoya-Morcillo MC, Algarra-Algarra JL, Ibañez-García Á, Hernández-Fernández F, Romero-Macías JR.
Marín-Sánchez A, et al. Among authors: gomez catalan i.
Exp Hematol. 2021 Sep;101-102:49-57. doi: 10.1016/j.exphem.2021.08.003. Epub 2021 Aug 14.
Exp Hematol. 2021.
PMID: 34403757
Free article.
Item in Clipboard
Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
Marín-Sánchez A, Martínez-Fernández G, Gómez-Catalán I, Montoya-Morcillo MC, Algarra JL, García ÁI, Hernández-Fernández F, Romero-Macías JR.
Marín-Sánchez A, et al. Among authors: gomez catalan i.
Ecancermedicalscience. 2021 Mar 22;15:1206. doi: 10.3332/ecancer.2021.1206. eCollection 2021.
Ecancermedicalscience. 2021.
PMID: 33912231
Free PMC article.
Item in Clipboard
Cite
Cite